-

SK Capital Completes the Sale of Isolatek International to Catchment Capital

STANHOPE, N.J.--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the material sciences, specialty ingredients and life sciences sectors, announced today they have completed the sale of Isolatek International (“Isolatek” or the “Company”), a leading manufacturer and supplier of passive fireproofing technologies, to Catchment Capital (“Catchment”), a New York-based private equity firm.

Isolatek is a market leader in the development, production, and distribution of proprietary passive fireproofing materials for data center, advanced manufacturing, institutional, and commercial applications. Founded in 1875, the Company has built a strong reputation for technical performance, regulatory compliance, and customer service. During SK Capital’s ownership, Isolatek executed a focused value creation strategy that expanded its product portfolio through organic investment and strategic acquisitions, strengthened its position in high-growth end markets, and reinforced its industry-leading technical capabilities.

“It has been a privilege to partner with Mike Harvey and the Isolatek team over nearly three years of significant transformation and growth,” said Jon Borell, Managing Director at SK Capital. “Together, we deepened the Company’s technical leadership, expanded into new markets, and built a more resilient and competitive business. SK Capital congratulates the Isolatek and Catchment teams on this milestone transaction.”

“This transaction marks an exciting new chapter for Isolatek,” said Mike Harvey, CEO of Isolatek. “Our partnership with SK Capital enabled us to expand our capabilities and deliver exceptional value to customers. I am proud of what our team has accomplished and look forward to building on that momentum with Catchment.”

“Through several strategic initiatives, including the acquisition of certain assets of Albi Protective Coatings and the launch of FireSolve® SB, we strengthened Isolatek’s product portfolio and accelerated the Company’s growth trajectory,” said Booey Ghani, Principal at SK Capital. “We are proud of what Mike and the entire Isolatek organization accomplished together with our team and wish them continued success as they begin this next chapter with Catchment.”

Evercore served as financial advisor and Goodwin Procter LLP as legal counsel to SK Capital and Isolatek.

About SK Capital:
SK Capital is a transformational private investment firm with a disciplined focus on the material sciences, specialty ingredients, and life sciences sectors. The firm seeks to build resilient, sustainable, and growing businesses that create substantial long-term value. SK Capital aims to utilize its industry, operating, and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth, and profitability, as well as lower operating risk. SK Capital has raised funds with over $9 billion in capital commitments since its inception. For more information, please visit skcapitalpartners.com.

About Catchment Capital:
Founded in 2024, Catchment Capital is a New York-based private equity firm focused on transforming middle market industrial technology, services and products companies. Catchment specializes in utilizing its proprietary Catchment Strategic Transformation (“CaST®”) process to guide industrial companies through investing in capabilities which catalyze growth and unlock inherent value. For more information, please visit catchmentcapital.com.

About Isolatek International:
Founded in 1875 and headquartered in Stanhope, New Jersey, Isolatek is recognized as a leader in the production and distribution of proprietary, best-in-class passive fireproofing materials for commercial, institutional, data center and advanced manufacturing applications. Isolatek’s branded portfolio of fireproofing and acoustical and insulation products are known for their exceptional thermal performance, superior durability, and ease of application. The Company’s portfolio consists of products certified by the relevant regulatory standards (i.e. UL, EN, BS) which are comprised of both intumescent and cementitious offerings, as well as complementary substrates to meet customer needs and preferences for structural projects. In addition to its technologies, Isolatek offers superior on-site support and technical service through the most experienced team in the industry to ensure installations meet the required specifications. For more information, please visit isolatek.com.

Contacts

Jeremy Milner
Gregory
jmilner@gregoryagency.com
(401) 862-9422

SK Capital Partners, LP


Release Versions

Contacts

Jeremy Milner
Gregory
jmilner@gregoryagency.com
(401) 862-9422

More News From SK Capital Partners, LP

Valtris Specialty Chemicals Announces New Chief Human Resources Officer

INDEPENDENCE, Ohio--(BUSINESS WIRE)--Valtris Specialty Chemicals, a leading global manufacturer of a comprehensive portfolio of specialty additives, announced today the appointment of Clint Shephard as the company’s new Chief Human Resources Officer. Mr. Shephard will play a key role in leading the company’s global talent strategy. Mr. Shephard will be based in the company’s new office in Midland, Michigan. Mr. Shephard most recently served as Senior Director of Human Resources at Myers Industr...

SK Capital Partners Completes the Sale of Phoenix Flavors & Fragrances to Turpaz Industries

NORWOOD, N.J.--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the material sciences, specialty ingredients, and life sciences sectors, announced today that it has completed the sale of Phoenix Flavors & Fragrances Inc. (“Phoenix” or the “Company”) to Turpaz Industries Ltd (TLV: TRPZ), a global developer, manufacturer, and marketer of specialty fragrance, flavor, and natural ingredient solutions for consumer and in...

SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG

NEW YORK--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have completed the sale of Noramco, Extractas Biosciences, and Purisys of the Noramco Group (“Noramco” or the “Company”) to Siegfried Holding AG (SIX: SFZN; “Siegfried”), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry....
Back to Newsroom